List of Tables
Table 1. Global Genetically Engineered Vector Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Genetically Engineered Vector Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Genetically Engineered Vector Vaccine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Genetically Engineered Vector Vaccine Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Genetically Engineered Vector Vaccine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Genetically Engineered Vector Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Genetically Engineered Vector Vaccine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Genetically Engineered Vector Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Genetically Engineered Vector Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Genetically Engineered Vector Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Genetically Engineered Vector Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Genetically Engineered Vector Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Genetically Engineered Vector Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genetically Engineered Vector Vaccine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Genetically Engineered Vector Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Genetically Engineered Vector Vaccine Sales by Region (2020-2025) & (K Units)
Table 18. Global Genetically Engineered Vector Vaccine Sales Market Share by Region (2020-2025)
Table 19. Global Genetically Engineered Vector Vaccine Sales by Region (2026-2031) & (K Units)
Table 20. Global Genetically Engineered Vector Vaccine Sales Market Share by Region (2026-2031)
Table 21. Global Genetically Engineered Vector Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Genetically Engineered Vector Vaccine Revenue Market Share by Region (2020-2025)
Table 23. Global Genetically Engineered Vector Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Genetically Engineered Vector Vaccine Revenue Market Share by Region (2026-2031)
Table 25. North America Genetically Engineered Vector Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Genetically Engineered Vector Vaccine Sales by Country (2020-2025) & (K Units)
Table 27. North America Genetically Engineered Vector Vaccine Sales by Country (2026-2031) & (K Units)
Table 28. North America Genetically Engineered Vector Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Genetically Engineered Vector Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Genetically Engineered Vector Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Genetically Engineered Vector Vaccine Sales by Country (2020-2025) & (K Units)
Table 32. Europe Genetically Engineered Vector Vaccine Sales by Country (2026-2031) & (K Units)
Table 33. Europe Genetically Engineered Vector Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Genetically Engineered Vector Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Genetically Engineered Vector Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Genetically Engineered Vector Vaccine Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Genetically Engineered Vector Vaccine Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Genetically Engineered Vector Vaccine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Genetically Engineered Vector Vaccine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Genetically Engineered Vector Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Genetically Engineered Vector Vaccine Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Genetically Engineered Vector Vaccine Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Genetically Engineered Vector Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Genetically Engineered Vector Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Genetically Engineered Vector Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Genetically Engineered Vector Vaccine Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Genetically Engineered Vector Vaccine Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Genetically Engineered Vector Vaccine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Genetically Engineered Vector Vaccine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Genetically Engineered Vector Vaccine Sales (K Units) by Type (2020-2025)
Table 51. Global Genetically Engineered Vector Vaccine Sales (K Units) by Type (2026-2031)
Table 52. Global Genetically Engineered Vector Vaccine Sales Market Share by Type (2020-2025)
Table 53. Global Genetically Engineered Vector Vaccine Sales Market Share by Type (2026-2031)
Table 54. Global Genetically Engineered Vector Vaccine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Genetically Engineered Vector Vaccine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Genetically Engineered Vector Vaccine Revenue Market Share by Type (2020-2025)
Table 57. Global Genetically Engineered Vector Vaccine Revenue Market Share by Type (2026-2031)
Table 58. Global Genetically Engineered Vector Vaccine Price (US$/Unit) by Type (2020-2025)
Table 59. Global Genetically Engineered Vector Vaccine Price (US$/Unit) by Type (2026-2031)
Table 60. Global Genetically Engineered Vector Vaccine Sales (K Units) by Application (2020-2025)
Table 61. Global Genetically Engineered Vector Vaccine Sales (K Units) by Application (2026-2031)
Table 62. Global Genetically Engineered Vector Vaccine Sales Market Share by Application (2020-2025)
Table 63. Global Genetically Engineered Vector Vaccine Sales Market Share by Application (2026-2031)
Table 64. Global Genetically Engineered Vector Vaccine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Genetically Engineered Vector Vaccine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Genetically Engineered Vector Vaccine Revenue Market Share by Application (2020-2025)
Table 67. Global Genetically Engineered Vector Vaccine Revenue Market Share by Application (2026-2031)
Table 68. Global Genetically Engineered Vector Vaccine Price (US$/Unit) by Application (2020-2025)
Table 69. Global Genetically Engineered Vector Vaccine Price (US$/Unit) by Application (2026-2031)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Pfizer Genetically Engineered Vector Vaccine Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Merck Company Information
Table 76. Merck Description and Business Overview
Table 77. Merck Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Merck Genetically Engineered Vector Vaccine Product
Table 79. Merck Recent Developments/Updates
Table 80. GSK Company Information
Table 81. GSK Description and Business Overview
Table 82. GSK Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. GSK Genetically Engineered Vector Vaccine Product
Table 84. GSK Recent Developments/Updates
Table 85. Wantai Biotechnology Company Information
Table 86. Wantai Biotechnology Description and Business Overview
Table 87. Wantai Biotechnology Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Wantai Biotechnology Genetically Engineered Vector Vaccine Product
Table 89. Wantai Biotechnology Recent Developments/Updates
Table 90. Watson Bio Company Information
Table 91. Watson Bio Description and Business Overview
Table 92. Watson Bio Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Watson Bio Genetically Engineered Vector Vaccine Product
Table 94. Watson Bio Recent Developments/Updates
Table 95. Bharat Biotech Company Information
Table 96. Bharat Biotech Description and Business Overview
Table 97. Bharat Biotech Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Bharat Biotech Genetically Engineered Vector Vaccine Product
Table 99. Bharat Biotech Recent Developments/Updates
Table 100. Sanofi Company Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Sanofi Genetically Engineered Vector Vaccine Product
Table 104. Sanofi Recent Developments/Updates
Table 105. Zoties Company Information
Table 106. Zoties Description and Business Overview
Table 107. Zoties Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Zoties Genetically Engineered Vector Vaccine Product
Table 109. Zoties Recent Developments/Updates
Table 110. Elanco Company Information
Table 111. Elanco Description and Business Overview
Table 112. Elanco Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Elanco Genetically Engineered Vector Vaccine Product
Table 114. Elanco Recent Developments/Updates
Table 115. Boehringer Ingelheim Company Information
Table 116. Boehringer Ingelheim Description and Business Overview
Table 117. Boehringer Ingelheim Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Boehringer Ingelheim Genetically Engineered Vector Vaccine Product
Table 119. Boehringer Ingelheim Recent Developments/Updates
Table 120. Indian Immunologicals Company Information
Table 121. Indian Immunologicals Description and Business Overview
Table 122. Indian Immunologicals Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Indian Immunologicals Genetically Engineered Vector Vaccine Product
Table 124. Indian Immunologicals Recent Developments/Updates
Table 125. Zhongmu Industrial Co., Ltd. Company Information
Table 126. Zhongmu Industrial Co., Ltd. Description and Business Overview
Table 127. Zhongmu Industrial Co., Ltd. Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Zhongmu Industrial Co., Ltd. Genetically Engineered Vector Vaccine Product
Table 129. Zhongmu Industrial Co., Ltd. Recent Developments/Updates
Table 130. Qingdao Yibang Bioengineering Co., Ltd. Company Information
Table 131. Qingdao Yibang Bioengineering Co., Ltd. Description and Business Overview
Table 132. Qingdao Yibang Bioengineering Co., Ltd. Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Qingdao Yibang Bioengineering Co., Ltd. Genetically Engineered Vector Vaccine Product
Table 134. Qingdao Yibang Bioengineering Co., Ltd. Recent Developments/Updates
Table 135. Jinyu Biotechnology Company Information
Table 136. Jinyu Biotechnology Description and Business Overview
Table 137. Jinyu Biotechnology Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Jinyu Biotechnology Genetically Engineered Vector Vaccine Product
Table 139. Jinyu Biotechnology Recent Developments/Updates
Table 140. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Company Information
Table 141. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Description and Business Overview
Table 142. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Genetically Engineered Vector Vaccine Product
Table 144. Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Recent Developments/Updates
Table 145. Tianjin Ruipu Biotechnology Company Information
Table 146. Tianjin Ruipu Biotechnology Description and Business Overview
Table 147. Tianjin Ruipu Biotechnology Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Tianjin Ruipu Biotechnology Genetically Engineered Vector Vaccine Product
Table 149. Tianjin Ruipu Biotechnology Recent Developments/Updates
Table 150. Kyoto Biken Laboratories Company Information
Table 151. Kyoto Biken Laboratories Description and Business Overview
Table 152. Kyoto Biken Laboratories Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Kyoto Biken Laboratories Genetically Engineered Vector Vaccine Product
Table 154. Kyoto Biken Laboratories Recent Developments/Updates
Table 155. FATRO Company Information
Table 156. FATRO Description and Business Overview
Table 157. FATRO Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. FATRO Genetically Engineered Vector Vaccine Product
Table 159. FATRO Recent Developments/Updates
Table 160. Ceva Santé Animale Company Information
Table 161. Ceva Santé Animale Description and Business Overview
Table 162. Ceva Santé Animale Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Ceva Santé Animale Genetically Engineered Vector Vaccine Product
Table 164. Ceva Santé Animale Recent Developments/Updates
Table 165. Pleco Company Information
Table 166. Pleco Description and Business Overview
Table 167. Pleco Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Pleco Genetically Engineered Vector Vaccine Product
Table 169. Pleco Recent Developments/Updates
Table 170. Wuhan Huisheng Biotechnology Company Information
Table 171. Wuhan Huisheng Biotechnology Description and Business Overview
Table 172. Wuhan Huisheng Biotechnology Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. Wuhan Huisheng Biotechnology Genetically Engineered Vector Vaccine Product
Table 174. Wuhan Huisheng Biotechnology Recent Developments/Updates
Table 175. Jinhe Biotechnology Company Information
Table 176. Jinhe Biotechnology Description and Business Overview
Table 177. Jinhe Biotechnology Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 178. Jinhe Biotechnology Genetically Engineered Vector Vaccine Product
Table 179. Jinhe Biotechnology Recent Developments/Updates
Table 180. Shenlian Biotechnology Company Information
Table 181. Shenlian Biotechnology Description and Business Overview
Table 182. Shenlian Biotechnology Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 183. Shenlian Biotechnology Genetically Engineered Vector Vaccine Product
Table 184. Shenlian Biotechnology Recent Developments/Updates
Table 185. Azure Creatures Company Information
Table 186. Azure Creatures Description and Business Overview
Table 187. Azure Creatures Genetically Engineered Vector Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 188. Azure Creatures Genetically Engineered Vector Vaccine Product
Table 189. Azure Creatures Recent Developments/Updates
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Genetically Engineered Vector Vaccine Distributors List
Table 193. Genetically Engineered Vector Vaccine Customers List
Table 194. Genetically Engineered Vector Vaccine Market Trends
Table 195. Genetically Engineered Vector Vaccine Market Drivers
Table 196. Genetically Engineered Vector Vaccine Market Challenges
Table 197. Genetically Engineered Vector Vaccine Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
Table 201. Authors List of This Report
List of Figures
Figure 1. Product Picture of Genetically Engineered Vector Vaccine
Figure 2. Global Genetically Engineered Vector Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Genetically Engineered Vector Vaccine Market Share by Type: 2024 & 2031
Figure 4. Viral Vector Vaccine Product Picture
Figure 5. Plasmid Vector Vaccine Product Picture
Figure 6. VLPV Product Picture
Figure 7. RNA Vaccine Product Picture
Figure 8. Global Genetically Engineered Vector Vaccine Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Genetically Engineered Vector Vaccine Market Share by Application: 2024 & 2031
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Global Genetically Engineered Vector Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Genetically Engineered Vector Vaccine Market Size (2020-2031) & (US$ Million)
Figure 15. Global Genetically Engineered Vector Vaccine Sales (2020-2031) & (K Units)
Figure 16. Global Genetically Engineered Vector Vaccine Average Price (US$/Unit) & (2020-2031)
Figure 17. Genetically Engineered Vector Vaccine Report Years Considered
Figure 18. Genetically Engineered Vector Vaccine Sales Share by Manufacturers in 2024
Figure 19. Global Genetically Engineered Vector Vaccine Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Genetically Engineered Vector Vaccine Players: Market Share by Revenue in Genetically Engineered Vector Vaccine in 2024
Figure 21. Genetically Engineered Vector Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Genetically Engineered Vector Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Genetically Engineered Vector Vaccine Sales Market Share by Country (2020-2031)
Figure 24. North America Genetically Engineered Vector Vaccine Revenue Market Share by Country (2020-2031)
Figure 25. United States Genetically Engineered Vector Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Genetically Engineered Vector Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Genetically Engineered Vector Vaccine Sales Market Share by Country (2020-2031)
Figure 28. Europe Genetically Engineered Vector Vaccine Revenue Market Share by Country (2020-2031)
Figure 29. Germany Genetically Engineered Vector Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Genetically Engineered Vector Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Genetically Engineered Vector Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Genetically Engineered Vector Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Genetically Engineered Vector Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Genetically Engineered Vector Vaccine Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Genetically Engineered Vector Vaccine Revenue Market Share by Region (2020-2031)
Figure 36. China Genetically Engineered Vector Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Genetically Engineered Vector Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Genetically Engineered Vector Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Genetically Engineered Vector Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Genetically Engineered Vector Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Genetically Engineered Vector Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Genetically Engineered Vector Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Genetically Engineered Vector Vaccine Sales Market Share by Country (2020-2031)
Figure 44. Latin America Genetically Engineered Vector Vaccine Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Genetically Engineered Vector Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Genetically Engineered Vector Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Genetically Engineered Vector Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Genetically Engineered Vector Vaccine Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Genetically Engineered Vector Vaccine Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Genetically Engineered Vector Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Genetically Engineered Vector Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Genetically Engineered Vector Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Genetically Engineered Vector Vaccine by Type (2020-2031)
Figure 54. Global Revenue Market Share of Genetically Engineered Vector Vaccine by Type (2020-2031)
Figure 55. Global Genetically Engineered Vector Vaccine Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Genetically Engineered Vector Vaccine by Application (2020-2031)
Figure 57. Global Revenue Market Share of Genetically Engineered Vector Vaccine by Application (2020-2031)
Figure 58. Global Genetically Engineered Vector Vaccine Price (US$/Unit) by Application (2020-2031)
Figure 59. Genetically Engineered Vector Vaccine Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
